


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.66%
-5.06%
+10.78%
-2.29%
ATNM
Actinium Pharmaceuti
$1.35
Strengths

Upgraded on attractively valued
Chart
$1.49 (-9.40%)
$1.47 (-8.16%)
$1.43 (-5.59%)
$1.42 (-4.93%)
ATNM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

ATNM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
ATNM Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ATNM Street view is extremely bullish and have positive views on the near-term outlook
ATNM Earnings
The TTM reflects 12-month period, providing review of ATNM financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is ATNM current stock price?
What are ATNM stock strengths?
What risks are associated with ATNM stock?
When is ATNM next earnings report?
What is ATNM market cap and volume?
What is ATNM's current Stock IQ?
Should I buy ATNM stock right now?
Is ATNM a Strong Buy right now?
What does a 'Strong Buy' rating mean for ATNM?
What does a 'Strong Sell' rating mean for ATNM?
What factors influence ATNM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.66%
-5.06%
+10.78%
-2.29%
ATNM
Actinium Pharmaceuti
Current Price
$1.35
Stock Insights
Strengths

Upgraded on attractively valued

Chart
$1.49 (-9.40%)
$1.47 (-8.16%)
$1.43 (-5.59%)
$1.42 (-4.93%)
ATNM Analysts Opinion
ATNM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
ATNM Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ATNM Street view is extremely bullish and have positive views on the near-term outlook
ATNM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

ATNM Earnings
The TTM data reflects the most recent 12-month period, providing overview of ATNM financial performance.
ATNM Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
ATNM Latest Analysis
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400 a First-in-Class Multi-Tumor Actinium-225 Radiotherapy at the 32nd Annual Prostate Cancer Foundation Scientific Retreat. - ATNM-400 targets a novel non-PSMA antigen implicated in disease biology with continued expression following androgen receptor pathway inhibitor (ARPI) therapy and 177Lu-PSMA-617 therapy enabling potent activity independent of PSMA expression - ATNM-400 demonstrated superior effic
Fri Oct 24, 2025
Actiniums ATNM-400 shows promising results in prostate cancer models.
Fri Oct 24, 2025
[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis Outlook Leaders Report Trends Forecast Segmentation Growth Rate Value SWOT Analysis). Radiopharmaceutical CDMO Market Size Trends and Insights By Application (Diagnostic Radiopharmaceuticals Therapeutic Radiopharmaceuticals) By Radioisotope Type (Technetium-99m Fluorine-18 Lutetium-177 Gallium-68 Actinium-225 Others) By Source of Manufacturing (Nuclear Reactor
Thu Oct 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ATNM Stock trends
ATNM Stock performance
ATNM Stock analysis
ATNM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.